Oral Oncology Reports最新文献

筛选
英文 中文
Does altered Ki67 expression in recurrent membranous basal cell adenoma point toward the need for reclassification? 复发性膜性基底细胞腺瘤中 Ki67 表达的改变是否表明需要重新分类?
Oral Oncology Reports Pub Date : 2024-08-16 DOI: 10.1016/j.oor.2024.100631
{"title":"Does altered Ki67 expression in recurrent membranous basal cell adenoma point toward the need for reclassification?","authors":"","doi":"10.1016/j.oor.2024.100631","DOIUrl":"10.1016/j.oor.2024.100631","url":null,"abstract":"<div><p>The pathogenesis of membranous BCA recurrence remains unclear, with only a few cases reported. The current study focuses on a case that exhibits a high Ki-67 proliferative index, which raises questions about its impact on the prognosis and treatment plan. We have conducted a literature review to gain insight into the altered ki67 expression pattern in membranous BCA. We have also proposed a hypothesis that suggests recurrent membranous BCA cases with Ki67 levels between 5 % and 10 % signify an intermediate grade and warrant reclassification. More research is needed to confirm this hypothesis and understand the prognosis for this variant.</p></div>","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772906024004771/pdfft?md5=4b84d5ce2885e710f048199ae20a4920&pid=1-s2.0-S2772906024004771-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142021228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of single nucleotide polymorphism of p16 gene in cytological samples of patients with oral potentially malignant disorders (OPMD) and oral squamous cell carcinoma (OSCC) 口腔潜在恶性疾病(OPMD)和口腔鳞状细胞癌(OSCC)患者细胞学样本中 p16 基因的单核苷酸多态性分析
Oral Oncology Reports Pub Date : 2024-08-15 DOI: 10.1016/j.oor.2024.100632
{"title":"Analysis of single nucleotide polymorphism of p16 gene in cytological samples of patients with oral potentially malignant disorders (OPMD) and oral squamous cell carcinoma (OSCC)","authors":"","doi":"10.1016/j.oor.2024.100632","DOIUrl":"10.1016/j.oor.2024.100632","url":null,"abstract":"<div><h3>Background</h3><p>pl6 (CDKN2a) play a role in tumorigenesis in some head and neck squamous cell carcinomas. Frequent homozygous deletions of the pl6 gene have been reported in many tumor cell lines including the brain, breast, osteosarcomas, melanomas, kidney, bladder, and ovary.</p></div><div><h3>Materials and methods</h3><p>5 patients without any tobacco using habit were included in group I as controls. 10 clinically and histopathologically confirmed cases of oral potentially malignant disorders (OPMDs) [oral submucous fibrosis (OSMF) −7 &amp; leukoplakia (moderate dysplasia) −3] were included in group II. 10 clinically and histopathologically confirmed cases of OSCC were categorized as group III. Buccal scrapings were taken and analyzed for exon 1, 2, 3 of p16 and homozygous deletion in exon 2 of p16 was also detected by PCR and gel electrophoresis.</p></div><div><h3>Results</h3><p>PCR amplification products of exon 1, 2, 3 of p16 were found in all 25 samples which include 10 cases of OSCC, 10 cases of OPMDs and 5 controls. Homozygous deletion in exon 2 was found only in 30 % of OSCC and 20 % of OPMD.</p></div><div><h3>Conclusion</h3><p>Our study showed that cytological samples yield sufficient amount of DNA, which showed 100 % positivity with exon 1, 2, 3 of p16 gene, but the percentage of genetic alteration of p16 gene seems to be less when compared with other related studies.</p></div>","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772906024004783/pdfft?md5=1abb5db1bf3ed21f7f5470bfc79d0195&pid=1-s2.0-S2772906024004783-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142012475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nivolumab (Opdivo) in PD-1 pathway inhibition: Enhancing immune response in recurrent oral squamous cell carcinoma 抑制 PD-1 通路的 Nivolumab (Opdivo):增强复发性口腔鳞状细胞癌的免疫反应
Oral Oncology Reports Pub Date : 2024-08-14 DOI: 10.1016/j.oor.2024.100630
{"title":"Nivolumab (Opdivo) in PD-1 pathway inhibition: Enhancing immune response in recurrent oral squamous cell carcinoma","authors":"","doi":"10.1016/j.oor.2024.100630","DOIUrl":"10.1016/j.oor.2024.100630","url":null,"abstract":"","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S277290602400476X/pdfft?md5=4395debc01eb9459fda6417ac9290b74&pid=1-s2.0-S277290602400476X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141990430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preserving academic integrity in the age of AI: Ethical guidelines for medical manuscript preparation 在人工智能时代维护学术诚信:医学稿件撰写伦理指南
Oral Oncology Reports Pub Date : 2024-08-14 DOI: 10.1016/j.oor.2024.100627
{"title":"Preserving academic integrity in the age of AI: Ethical guidelines for medical manuscript preparation","authors":"","doi":"10.1016/j.oor.2024.100627","DOIUrl":"10.1016/j.oor.2024.100627","url":null,"abstract":"","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772906024004734/pdfft?md5=4abe224268021f3b52faa61b17037595&pid=1-s2.0-S2772906024004734-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142012476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perspective on enhancing quality of life in oral cancer patients: Integrative approaches and comprehensive care 提高口腔癌患者生活质量的视角:综合方法和全面护理
Oral Oncology Reports Pub Date : 2024-08-12 DOI: 10.1016/j.oor.2024.100633
{"title":"Perspective on enhancing quality of life in oral cancer patients: Integrative approaches and comprehensive care","authors":"","doi":"10.1016/j.oor.2024.100633","DOIUrl":"10.1016/j.oor.2024.100633","url":null,"abstract":"<div><p>Oral cancer poses a global health challenge with high morbidity and mortality rates. Treatments, including surgery, radiation, and chemotherapy, profoundly impact patients' quality of life (QoL). Enhancing QoL requires a comprehensive approach that integrates physical health management, psychological support, social support, and integrative and palliative care.</p><p>Effective pain management, nutritional support, and oral rehabilitation are crucial for maintaining physical health. Psychological support through counseling, psychotherapy, and mind-body interventions addresses emotional distress. Social support from family, caregivers, and community resources is essential for practical and emotional needs. Integrative care approaches and early palliative care provide holistic, patient-centered solutions.</p><p>This manuscript emphasizes the necessity of a holistic approach to improve the QoL for oral cancer patients, advocating for comprehensive, compassionate care plans that address physical, emotional, and social dimensions.</p></div>","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772906024004795/pdfft?md5=16924daffca05fbee2ee0d909db84beb&pid=1-s2.0-S2772906024004795-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142021227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genomic landscape of head and neck cancer in Asia: A comprehensive meta-analysis of 1016 samples 亚洲头颈癌的基因组状况:对 1016 个样本的综合荟萃分析
Oral Oncology Reports Pub Date : 2024-08-10 DOI: 10.1016/j.oor.2024.100628
{"title":"Genomic landscape of head and neck cancer in Asia: A comprehensive meta-analysis of 1016 samples","authors":"","doi":"10.1016/j.oor.2024.100628","DOIUrl":"10.1016/j.oor.2024.100628","url":null,"abstract":"<div><p>Head and neck cancer (HNC) is a diverse group of malignancies arising in the mucosal linings of the oral cavity, pharynx, and larynx, influenced by factors such as tobacco use, alcohol consumption, and human papillomavirus (HPV) infection. This study conducts a comprehensive meta-analysis of the mutational landscape of HNC across Asian cohorts, encompassing India, Korea, Japan, China, Singapore, and Saudi Arabia. The analysis highlights distinct genetic profiles influenced by environmental exposures, lifestyle habits, and genetic predispositions. Notably, the RAF family proteins, enriched in both Indian and Chinese cohorts, present potential therapeutic targets for RAF inhibitors like Vemurafenib. Additionaly, specific mutations like MET in Singaporean patients can be effectively addressed with drugs like Crizotinib, leading to rapid responses in HNSCC. Smokers exhibited high frequencies of CASP8 and FAT1 mutations. Novel driver genes, including RYR2 and ANK2, emerged with significant mutational frequencies in smokers. The RAS signaling pathway was identified as a prominent driver in HNC, contrasting with the globally prevalent PIK3CA/MTOR pathway. This study also underscores the high prevalence of HRAS mutations in Indian and Saudi cohorts. The study emphasizes the necessity for region-specific data to understand the unique molecular differences and develop effective therapies. The identification of NBEA and ANK2 as potential novel driver genes in HNC highlights new avenues for research and targeted therapeutic interventions tailored to the genetic profiles of Asian HNC patients.</p></div>","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772906024004746/pdfft?md5=6cbe8b6837cd60e62c63b42b459d39b0&pid=1-s2.0-S2772906024004746-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141990429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reevaluating clinical staging: Recent advances in AJCC/UICC criteria for nasopharyngeal carcinoma 重新评估临床分期:AJCC/UICC鼻咽癌标准的最新进展
Oral Oncology Reports Pub Date : 2024-08-08 DOI: 10.1016/j.oor.2024.100621
{"title":"Reevaluating clinical staging: Recent advances in AJCC/UICC criteria for nasopharyngeal carcinoma","authors":"","doi":"10.1016/j.oor.2024.100621","DOIUrl":"10.1016/j.oor.2024.100621","url":null,"abstract":"","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772906024004679/pdfft?md5=c06518446f5d2f0fff2c08b5a0fc4081&pid=1-s2.0-S2772906024004679-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141985698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circulating tumor DNA as a therapeutic approach for HPV (+) oropharyngeal squamous cell carcinoma 将循环肿瘤 DNA 作为治疗 HPV(+)口咽鳞状细胞癌的一种方法
Oral Oncology Reports Pub Date : 2024-08-08 DOI: 10.1016/j.oor.2024.100626
{"title":"Circulating tumor DNA as a therapeutic approach for HPV (+) oropharyngeal squamous cell carcinoma","authors":"","doi":"10.1016/j.oor.2024.100626","DOIUrl":"10.1016/j.oor.2024.100626","url":null,"abstract":"","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772906024004722/pdfft?md5=1fe1180b58737504ee7b0a1827f8b7f0&pid=1-s2.0-S2772906024004722-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141990431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine learning-driven insights into ctDNA for oral cancer: Applications, models, and future prospects 机器学习驱动的口腔癌ctDNA洞察力:应用、模型和未来展望
Oral Oncology Reports Pub Date : 2024-08-06 DOI: 10.1016/j.oor.2024.100629
{"title":"Machine learning-driven insights into ctDNA for oral cancer: Applications, models, and future prospects","authors":"","doi":"10.1016/j.oor.2024.100629","DOIUrl":"10.1016/j.oor.2024.100629","url":null,"abstract":"<div><p>Circulating tumor DNA (ctDNA) offers a promising non-invasive approach for early cancer detection, treatment monitoring, and personalized medicine, particularly in oral cancer. This review explores the clinical applications, challenges, and future prospects of ctDNA analysis. We highlight the integration of advanced machine learning (ML) models—Support Vector Machines (SVM), Random Forests (RF), Artificial Neural Networks (ANN), and Convolutional Neural Networks (CNN)—in ctDNA detection and analysis. These models significantly enhance the accuracy and reliability of ctDNA analysis, with accuracies reaching up to 93 %. SVM and RF models excel in classification and feature selection, while ANN and CNN models capture complex and spatial patterns, respectively. Despite challenges such as low ctDNA abundance and the need for standardized protocols, ML-driven ctDNA analysis holds immense potential for revolutionizing cancer diagnostics and treatment.</p></div>","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772906024004758/pdfft?md5=5c03a909e8b582307551d6ca8ee6dfa0&pid=1-s2.0-S2772906024004758-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141952529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving oral cancer diagnosis and management with artificial intelligence: A promising future for patient care 利用人工智能改进口腔癌诊断和管理:患者护理的美好未来
Oral Oncology Reports Pub Date : 2024-08-03 DOI: 10.1016/j.oor.2024.100624
{"title":"Improving oral cancer diagnosis and management with artificial intelligence: A promising future for patient care","authors":"","doi":"10.1016/j.oor.2024.100624","DOIUrl":"10.1016/j.oor.2024.100624","url":null,"abstract":"","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772906024004709/pdfft?md5=1a82fb9943b69dcc7a4e65b646c638a1&pid=1-s2.0-S2772906024004709-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141952528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信